- Home
- DRTS vs PROF Comparison
DRTS vs PROF Comparison
Compare DRTS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- PROF
- Stock Information
- Founded
- DRTS 2015
- PROF N/A
- Country
- DRTS Israel
- PROF Canada
- Employees
- DRTS N/A
- PROF N/A
- Industry
- DRTS Medical/Dental Instruments
- PROF Medical/Dental Instruments
- Sector
- DRTS Health Care
- PROF Health Care
- Exchange
- DRTS Nasdaq
- PROF Nasdaq
- Market Cap
- DRTS 211.7M
- PROF 201.2M
- IPO Year
- DRTS N/A
- PROF N/A
- Fundamental
- Price
- DRTS $2.55
- PROF $5.53
- Analyst Decision
- DRTS Strong Buy
- PROF Strong Buy
- Analyst Count
- DRTS 2
- PROF 1
- Target Price
- DRTS $8.00
- PROF $12.00
- AVG Volume (30 Days)
- DRTS 32.4K
- PROF 66.5K
- Earning Date
- DRTS 03-12-2025
- PROF 03-06-2025
- Dividend Yield
- DRTS N/A
- PROF N/A
- EPS Growth
- DRTS N/A
- PROF N/A
- EPS
- DRTS N/A
- PROF N/A
- Revenue
- DRTS N/A
- PROF $10,680,000.00
- Revenue This Year
- DRTS N/A
- PROF $165.23
- Revenue Next Year
- DRTS N/A
- PROF $96.94
- P/E Ratio
- DRTS N/A
- PROF N/A
- Revenue Growth
- DRTS N/A
- PROF 48.35
- 52 Week Low
- DRTS $1.75
- PROF $4.75
- 52 Week High
- DRTS $4.39
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- DRTS 39.29
- PROF 24.81
- Support Level
- DRTS $2.60
- PROF $4.75
- Resistance Level
- DRTS $2.68
- PROF $7.15
- Average True Range (ATR)
- DRTS 0.14
- PROF 0.47
- MACD
- DRTS 0.01
- PROF -0.14
- Stochastic Oscillator
- DRTS 28.26
- PROF 32.29
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.